Dyment D et al. De novo substitutions of TRPM3 cause intellectual disability and epilepsy.Eur J Hum Genet. 2019;27(10):1611-1618. PMID: 31278393.
Lines M et al. Phenotypic spectrum of the recurrent TRPM3 p.(Val837Met) substitution in seven individuals with global developmental delay and hypotonia. Am J Med Genet A. 2022;188(6):1667-1675 PMID: 35146895.
Zhao S et al. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.Elife. 2020 ;9:e55634 PMID: 32343227.
Van Hoeymissen E et al. Gain of channel function and modified gating properties in TRPM3 mutants causing intellectual disability and epilepsy.Elife. 2020;9:e57190 PMID: 32427099.
Sundaramurthi JC et al. De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy.Cold Spring Harb Mol Case Stud 2023;9:a006293. PMID: 37684057.
Burglen L et al. Gain-of-function variants in the ion channel gene TRPM3underlie a spectrum of neurodevelopmental disorders.Elife. 2023;12:e81032. PMID: 36648066.
Becker L et al. Primidone improves symptoms in TRPM3-linked developmental and epileptic encephalopathy with spike-and-wave activation in sleep.Epilepsia. 2023;64(5):e61-e68. PMID: 36929095.
Bazeli et al. Stereoselectivity and functional plasticity of a common ligand-binding pocket in TRPM3. Nature Comm. 2026.
Roelens R et al. Neurodevelopmental disorders caused by variants in TRPM3.Biochim Biophys Acta Mol Cell Res 2024 ;1871(5):119709. PMID: 38522727.
Jolitz L et al. Phenotype spectrum of TRPM3-associated disorders.Ann Neurol. 2025;97(3):561-570 PMID: 39749750.
TRPM3